España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Novo Nordisk
NVO
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$85.00
-18.44
-17.83%
At close: -
$86.20
1.20
1.41%
After Hours: 7:59 PM EDT
Get Report
Comment
Novo Nordisk (NVO) Forecast
News
Earnings
Novo Nordisk (NVO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Novo Nordisk (NYSE:NVO) Stock
Novo Nordisk Stock (NYSE: NVO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 20, 2024
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Benzinga Market Summary: S&P Rises On PCE Dat...
Benzinga Newsdesk
Dow Surges Over 600 Points, Gold Jumps 1.5%
Avi Kapoor
Wall Street Rallies On Soft Inflation Data, Bonds Rebound, Travel Stocks Surge: What's Driving Markets Friday?
Piero Cingari
What's Going On With Amgen Stock On Friday?
Vandana Singh
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
Avi Kapoor
Novo Nordisk Stock Plummets: Bearish Signals Dominate After Drug Trial Miss
Surbhi Jain
EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss
Piero Cingari
Benzinga Market Summary: Novo Nordisk Falls O...
Benzinga Newsdesk
CORRECTION: Amgen shares are trading higher. ...
Benzinga Newsdesk
Top 10 Trending Stocks On WallStreetBets As O...
Benzinga Newsdesk
US Steel Issues Weak Q4 Outlook, Joins Novo Nordisk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Novo Nordisk shares are trading lower. The co...
Benzinga Newsdesk
Novo Nordisk's Hybrid Weight Loss Drug Falls Short On Expectations, Stock Plunges
Vandana Singh
Novo Nordisk Spokesperson Said Regulatory Sub...
Benzinga Newsdesk
Novo Nordisk Spokesperson Said Cagrisema Tria...
Benzinga Newsdesk
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Novo Nordisk Says CagriSema Demonstrates Weig...
Benzinga Newsdesk
Thursday, December 19, 2024
Elon Musk Vs. RFK Jr.: Obesity Crisis Debate Sparks Struggle For Trump's Influence
Maureen Meehan
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Vandana Singh
Wednesday, December 18, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Novo Nordisk's Ozempic Under Scrutiny For Potential Increased Risk Of Rare-Eye Disease
Vandana Singh
Tuesday, December 17, 2024
Novo Nordisk's Options Frenzy: What You Need to Know
Benzinga Insights
Monday, December 16, 2024
Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent
Vandana Singh
Reported Earlier Today, Novo Nordisk Plans To...
Benzinga Newsdesk
Friday, December 13, 2024
Market Whales and Their Recent Bets on NVO Options
Benzinga Insights
Novo Nordisk's Ozempic Potentially Linked To Rare Vision Loss Risk, But Absolute Risk Is Low: Study
Vandana Singh
Novo Nordisk shares are trading lower followi...
Benzinga Newsdesk
'Ozempic Link to Rare Vision Loss Risk Confir...
Benzinga Newsdesk
"Weight-Loss Drug Craze Appears To Be Curbing...
Benzinga Newsdesk
Thursday, December 12, 2024
Novo Nordisk's Ozempic Label Expansion Snags Approval From European Drug Regulator's Advisory Panel
Vandana Singh
Telehealth Firm Ro Partners With Eli Lilly to Boost Access to Obesity Drug Zepbound
Vandana Singh
European Medicines Agency's Committee For Me...
Benzinga Newsdesk
Wednesday, December 11, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Evotec And Novo Nordisk Launch First Projects...
Benzinga Newsdesk
Tuesday, December 10, 2024
Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'
Avi Kapoor
Monday, December 09, 2024
Novo Nordisk Says Investment Aimed At Expandi...
Benzinga Newsdesk
Novo Nordisk To Invest Additional 500M Reais ...
Benzinga Newsdesk
Saturday, December 07, 2024
Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt
Anthony Noto
Friday, December 06, 2024
EU Regulators Say Novo Holdings Secures Uncon...
Benzinga Newsdesk
Thursday, December 05, 2024
How Much Did Americans Overspend On Weight Loss Medications in 2024? GoodRx Reveals
Vandana Singh
Wednesday, December 04, 2024
Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million
Vandana Singh
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Stock Of The Day: Where Will The Eli Lilly Rally End?
Mark Putrino
Eli Lilly's Zepbound Vs. Novo Nordisk's Wegovy - Which Shows Greater Weight Loss?
Vandana Singh
Novavax Sells Czech Republic Manufacturing Fa...
Benzinga Newsdesk
Tuesday, December 03, 2024
'ADA Advises Against Using Compounded GLP-1 R...
Benzinga Newsdesk
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
Surbhi Jain
Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum
Vandana Singh
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch